Major pharmaceutical companies are increasingly adopting artificial intelligence (AI) across various stages, from drug discovery to clinical trials. In this competitive landscape, AstraZeneca has distinguished itself by deploying AI technology for clinical trials at an unprecedented public health scale.
While many competitors focus on optimizing internal research and development (R&D) pipelines, AstraZeneca's AI is already embedded within national healthcare systems. This technology has facilitated the screening of hundreds of thousands of patients, demonstrating the tangible impact of AI in real-world applications.